Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,799 total articles
XTEND, a software and AI-powered robotics company, has completed delivery of hundreds of M6F tactical intelligence, surveillance and reconnaissance (ISR) systems to a defense customer in the Asia-Pacific region. These lightweight, portable ISR systems enable frontline soldiers to conduct indoor and outdoor missions effectively. The deliveries reinf…
Wellchange Holdings Company Limited, a Hong Kong-based enterprise software solutions provider listed on NASDAQ as WCT, announced it is pricing a public offering of 50 million Class A ordinary shares at $0.15 per share to raise approximately $7.5 million. The offering is expected to close around August 31, 2026, subject to customary conditions, with…
Amarin Corporation presented a new post hoc analysis from the REDUCE-IT cardiovascular outcomes trial at ESC 2026, indicating that patients highly adherent to Icosapent Ethyl (IPE) treatment experienced significant reduction in major adverse cardiovascular events, with benefits lasting years after treatment stopped. This 'legacy effect' underscores…
Aprea Therapeutics announced an expansion of its intellectual property portfolio, enhancing protection for its WEE1 kinase inhibitor APR-1051 and ATR inhibitor ATRN-119 programs. The patent estate extends exclusivity into 2045-2047, reinforcing the company's focus on developing targeted therapies for biomarker-defined cancers. This move supports th…
ENvue Medical, Inc., a Nasdaq-listed medical technology company specializing in non-invasive enteral care solutions, announced a 1-for-12 reverse stock split effective September 1, 2026. The reverse split reduces the number of outstanding shares from approximately 11 million to about 924,000, aims to consolidate shares without affecting overall sha…
Minerva Neurosciences, a clinical-stage biopharmaceutical company focused on CNS disorders, announced that its management will participate in two upcoming investor conferences in New York, including the Wells Fargo Healthcare Conference and the 2026 Cantor Global Healthcare Conference. The company will webcast its presentations and provide replay a…
Rezolve Ai, a US-listed AI-powered commerce technology company, has formed a global strategic alliance with Tech Mahindra, a leading Indian technology consulting firm, to accelerate large-scale deployment of agentic commerce. The partnership leverages Rezolve Ai's Brain Suite AI platform and Tech Mahindra's global consulting and integration capabil…
Nano Labs Ltd, a Nasdaq-listed Web 3.0 infrastructure and crypto treasury company, announced its unaudited financial results for H1 2026, reporting a net loss of RMB316.7 million (US$46.5 million), a sharp decline compared to the same period in 2025. The company attributed losses primarily to decreased cryptocurrency valuations, especially BNB, and…
Core AI Holdings reported strong Q2 2026 financial results with 56% year-over-year revenue growth to $22.4 million and a 97% reduction in gross loss, bringing its gross margin close to breakeven. The improvement was driven by optimized advertising and user acquisition strategies, particularly in its AI-enabled mobile gaming segment. The company als…
Mobia Medical announces that implantable paired Vagus Nerve Stimulation (VNS) has been recognized in the 2026 American Heart Association (AHA) stroke rehabilitation guidelines as a treatment option to improve upper-limb function in chronic stroke survivors. Their FDA-approved Vivistim® Paired VNS System is the only device delivering this therapy. T…
Hecate Energy and EGH Acquisition Corp. announced the resolution of lender and litigation matters, enabling progress toward Hecate's planned Nasdaq listing under ticker 'HCTE' via a business combination with EGH. The transaction, valuing Hecate at $1.2 billion pre-money, is expected to close in Q1 2027, providing capital to develop and monetize Hec…
Chagee Holdings Limited announced its Q2 2026 unaudited financial results, showing a 2.5% increase in net revenues to RMB3.41 billion and a substantial 387.6% rise in operating income to RMB524.7 million. Despite revenue growth, same store GMV declined 16.1% in Greater China due to economic headwinds and intense competition. The company's teahouse …
iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotech company, announced its FY 2026 financial results and highlighted significant advancements including the initiation of Phase 1 clinical trials for IBIO-600 and IND-enabling studies for IBIO-610 and IBIO-800. The company strengthened its leadership, secured substantial financing extending its cash r…
XORTX Therapeutics Inc. has terminated its investor relations agreement with IR Agency LLC and returned the previously paid marketing fees, opting to postpone its investor relations program while completing its voluntary delisting from the TSX Venture Exchange. The company aims to reduce regulatory complexity and focus on advancing its pharmaceutic…
MoneyHero Limited, a Nasdaq-listed fintech company specializing in AI-powered personal finance aggregation and digital insurance brokerage in Greater Southeast Asia, announced it will release its Q2 2026 results on September 11, 2026, before market open and host a conference call. The firm operates across Singapore, Hong Kong, Taiwan, and the Phili…
Teva Pharmaceutical Industries Ltd. has announced a proposed acquisition of the novel dexmedetomidine sublingual film product, BXCL501, from BioXcel Therapeutics through a court-supervised sale process. The product is under FDA review for at-home treatment of agitation in adults with schizophrenia or bipolar disorder, potentially becoming the first…
Netcapital Inc. announced that it received a notification from Nasdaq for failing to timely file its Annual Report on Form 10-K for the fiscal year ended April 30, 2026. The company has 60 days to submit a plan to regain compliance and could be granted up to 180 days to file the report if Nasdaq accepts the plan. There is uncertainty whether the co…
Immuron Limited reported preliminary financial results for FY26, exceeding sales and profit projections with record A$7.7 million sales, driven by growth in Australia and the U.S. The company achieved key clinical milestones including FDA IND approval for IMM-529 and U.S. Department of Defense-funded research collaborations. Immuron plans to invest…
Quoin Pharmaceuticals announced a private placement financing to raise up to $50 million, including upfront funding of approximately $30.8 million, aimed at supporting the completion of clinical development programs for rare and orphan disease therapies, particularly for Netherton Syndrome. The proceeds are expected to fund operations through mid-2…
Jiayin Group Inc., a fintech platform listed on NASDAQ, reported a sharp decline in its Q2 2026 financial performance with a 74.4% drop in transaction volume to RMB9.5 billion and a net loss of RMB183.6 million compared to net income of RMB519.1 million in the same period last year. The company is transitioning its strategy from scale-driven growth…
Quoin Pharmaceuticals announced positive interim results from its ongoing Phase 2/3 study evaluating QRX003 4% lotion in patients with Netherton Syndrome. The study showed that 66.7% of the first six patients achieved a significant improvement in skin condition after 12 weeks of treatment, meeting the trial's primary endpoint with statistical signi…
BioXcel Therapeutics announced its entry into a court-supervised Chapter 11 bankruptcy process and an asset sale agreement with Teva Pharmaceuticals, which will act as the stalking horse bidder for the company's assets, including its drug IGALMI®. The company secured $19 million in DIP financing to support ongoing operations during the bankruptcy p…
Cytokinetics announced positive top-line results from its ACACIA-HCM Phase 3 trial evaluating aficamten in symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM). The trial met dual primary endpoints showing statistically significant improvements in patient-reported outcomes and exercise capacity compared to placebo. Based on these results,…
CDT Equity Inc. announced validation of new solid drug forms with improved physical properties such as stability and solubility, secured by patents in their intellectual property portfolio. These innovations enable tailored formulations for underserved patient groups and extend the commercial life of existing assets. By integrating AI-driven data a…
GCL Global Holdings Ltd., a Nasdaq-listed gaming and entertainment company, announced a board-approved $10 million share buyback program to repurchase ordinary shares over the next 12 months. This action reflects management's confidence in the company's long-term growth prospects and financial strength, particularly focusing on the expanding Asian …
